Table 1.
Variable | Overall (n = 12,538) | Procedural Success (n = 12,000) | Procedural Failure (n = 538) | p Value |
---|---|---|---|---|
Age (years) * | 69.3 ± 10.4 | 69.3 ± 10.4 | 69.9 ± 10.2 | 0.402 |
Men | 77.2% | 77.2% | 77.5% | 0.871 |
BMI (kg/m2) * | 28.0 ± 4.6 | 28.0 ± 4.6 | 27.8 ± 4.7 | 0.342 |
Diabetes Mellitus | 29.7% | 29.4% | 35.4% | 0.005 |
Hypercholesterinemia | 88.5% | 88.4% | 90.8% | 0.103 |
Hypertension | 86.8% | 86.7% | 89.0% | 0.125 |
Smoking (current) | 14.6% | 14.5% | 15.8% | 0.413 |
Left Ventricular Ejection Fraction ‡ | 0.069 | |||
● Normal | 71.9% | 72.1% | 66.6% | |
● Moderately reduced | 16.0% | 15.9% | 18.9% | |
● Reduced | 7.5% | 7.5% | 8.7% | |
● Low | 4.6% | 4.5% | 5.8% | |
Family History of CAD | 41.3% | 41.5% | 37.6% | 0.099 |
Heart Failure | 4.1% | 5.6% | 4.1% | 0.099 |
NYHA Classification | 0.523 | |||
● I | 17.2% | 17.2% | 17.4% | |
● II | 47.7% | 47.8% | 44.4% | |
● III | 32.2% | 32.1% | 35.3% | |
● IV | 2.9% | 2.9% | 2.9% | |
Prior MI | 29.5% | 29.3% | 34.5% | 0.015 |
Prior CABG | 14.4% | 14.0% | 22.1% | <0.001 |
eGFR (mL/min/1.732) * | 71.3 ± 19.5 | 71.9 ± 19.4 | 69.4 ± 20.9 | 0.038 |
Baseline Creatinine (mg/dL) † | 1.00 (0.88, 1.20) | 1.00 (0.88, 1.20) | 1.00 (0.88, 1.22) | 0.096 |
* mean ± standard deviation; † median (interquartile range). ‡ Left ventricular function groups are indicated as follows: normal (52–100%) moderately reduced (41–51%), reduced (30–40%), and low (0–29%) in males; and normal (54–100%), moderately reduced (41–53%), reduced (30–40%), and low (0–29%) in females. BMI, body mass index; CABG, coronary artery bypass graft; CAD, coronary artery disease; eGFR, estimated glomerular filtration rate; MI, myocardial infarction; NYHA, New York Heart Association.